Delivery Order SPE2DB22D2206-SPE2DB23FKP38
Award Date 9/27/23
Potential Completion Date 10/19/23
Potential Value $4.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,075.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. The delivery order was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding on July 21, 2023. The delivery order provides a specified quantity of the Zoladex implant to...
- The Defense Logistics Agency awarded a $15,227 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. As the prime contractor, Amerisourcebergen will supply the implants to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA contract vehicle and has a period of performance from June 22, 2023 through July 14, 2023. No set aside designation or subcontractors were identified....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,578.44 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order was awarded on October 24, 2025, with an ultimate completion date of November 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zoladex is a gonadotropin-releasing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a contract ceiling value of $37,190. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,334.59 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This non-set-aside, firm fixed-price delivery order was competitively awarded on December 11, 2025, with an ultimate completion date of January 5, 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $6,768 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. The prime contractor will provide the pharmaceutical products from its Conshohocken, Pennsylvania location to support DLA requirements. Amerisourcebergen will deliver the prescription implants under a one-month period of performance ending in mid-August 2023. No set aside designation or subcontractors were identified. The award draws upon DLA's Medical...
- The Defense Logistics Agency awarded a $3,383.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. The implants will be provided under contract number 4561617893 and delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 15, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supplies medical materials to support the military health system. This delivery order for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,564.32 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $9,798.10 and a firm fixed price structure. This non-set-aside contract is set to complete by December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $2,538 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. As the prime contractor, Amerisourcebergen will supply the injectable drug used to treat prostate cancer to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania. Performance is required between August 23 and September 14, 2023. The delivery order was placed against an existing DLA contract vehicle, though details were not...